In Science this week: global genetic diversity map, and more.

A retrospective review of panel sequencing data presented at the National Society of Genetic Counselors conference linked BRCA2 to primary brain cancer cases.

Under the contract, DNAe will develop tests for antimicrobial resistant infections and influenza that it submits to the FDA for clearance. 

Frameshift plans to commercialize two applications: one for data quality control and a second for identifying mutations in rare and Mendelian disorders.

A brief recap of Genetics/Genomics news the week of Sep 30, 2016: May Clinic, Vela Diagnostics, MNG Laboratories, and Rx30.

The Nuffield Council report is the first step in addressing ethical considerations of genome editing in human health, food, and the natural environment.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.

Premaitha said it has sold more than 17,000 of the tests, which is the focus of an ongoing patent-infringement suit, since its launch in early 2015.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

Recently presented studies support the utility of Genestrat and Veristrat for detecting actionable mutations and guiding therapy in drug-resistant lung cancer patients.

The company has decided to put its direct-to-consumer sequencing campaign on hold after receiving a letter from the FDA.

ReadCoor is currently using its its technology to map neural circuits in the brain and has projects in the pipeline related to oncology and infectious disease.

During a live webcast, CTO Clive Brown provided an update on the company's development plans and upcoming updates.

Participants of the National Society of Genetic Counselors annual education conference highlighted the need for consensus guidelines for screening potential gamete donors. 

DNAStar has launched Lasergene 14 software. The update includes three new applications: GenVision Pro, a comprehensive genome browser; NovaDock, a protein-protein docking application; and NovaFold Antibody, a specific antibody structure prediction program. It also includes enhancements to virtual cloning with three new cloning methods, newly integrated combined next-generation sequencing workflows, enhancements to the de novo transcriptome workflow introduced with Lasergene 13, and a workflow in support of Sanger validation of NGS data, the company said. 

The bill, which would boost NIH funding among other things, was overwhelmingly approved by the House and cleared a Senate subcommittee, but has stalled amid negotiations over appropriations.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

The service combines PathoQuest's proprietary curated virus database with an automatic analysis pipeline to identify viral contaminants in biological products.

A University of Copenhagen-led team found that regions with high levels of human activity harbor lower levels of amphibian genetic diversity.

DuPont Pioneer has entered into a collaboration to apply CRISPR genome editing to the development of crop varieties for farmers in developing countries.

Two Broad Institute teams, led by Eric Lander and Feng Zhang, respectively, have published new papers today in Science on new uses for lenti-CRISPR screens.

China-based Burning Rock will develop cancer diagnostics for Chinese patients based on the Agilent SureSelect target enrichment system.